Prime Medicine-JPM-20240108.pdf

1、1Delivering on the promise of Prime EditingJanuary 2024JP Morgan Healthcare Conference2This presentation contains forward-looking statements of Prime Medicine,Inc.(Prime,we or our)within the meaning of the Private Securities Litigation Reform Act of 1995,as amended.These forward-looking statements c

2、ontain information about our current and future prospects and our operations,which are based on currently available information.All statements other than statements of historical facts contained in this presentation,including statements regarding our strategy,projects and plans are forward-looking s

3、tatements.In some cases,you can identify forward-looking statements by terminology such as“aim,”“anticipate,”“assume,”“believe,”“contemplate,”“continue”“could,”“design,”“due,”“estimate,”“expect,”“goal,”“hope,”“intend,”“may,”“might,”“objective,”“opportunity,”“plan,”“predict,”“positioned,”“possible,”“

4、potential,”“project,”“seek,”“should,”“strategy,”“target,”“will,”“would”and other similar expressions that are predictions of or indicate future events and future trends,or the negative of these terms or other comparable terminology.These forward-looking statements include,but are not limited to,expr

5、ess or implied statements about Primes beliefs and expectations regarding:the initiation,timing,progress and results of our research and development programs,preclinical studies and future clinical trials,and the release of data related thereto;our ability to demonstrate,and the timing of,preclinica

6、l proof-of-concept in vivo for multiple programs;our ability to pursue our four strategic indication categories:immediate target indications,differentiation target indications,“blue sky”indications and“march up the chromosome”approaches;our ability to quickly leverage programs within our initial tar